Drug recall · May 31, 2017
Alprazolam Extended-release Tablets recall
Why: Failed Dissolution Specifications
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Alprazolam Extended-release Tablets, USP, 1 mg, 60-count bottle, Rx Only, Manufactured and Distributed by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5022-91
- Lots / codes
Code: 0378-5022-91 Lot: 3065878; Exp. 04/17
- Quantity
- 24,176 bottles (1,450,560 tablets)
- Company
- Mylan Pharmaceuticals Inc., Morgantown, WV
- Distribution
- Nationwide
- Initiated
- June 22, 2016 · Voluntary: Firm initiated
- Classified
- May 24, 2017
- Reported
- May 31, 2017
- Ended
- July 12, 2017
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Alprazolam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.